Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Elekta ABEKTAF 70 PB Ratio is 2.62 as of Jul. 18, 2026, which is 36% below its 10-year median of 4.12. GuruFocus rates EKTAF with a GF Score™ of 70/100 and a GF Value™ of $6.70 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Elekta AB ranks worse than 58.32% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-18), Elekta AB's share price is $5.2501. Elekta AB's Book Value per Share for the quarter that ended in Apr. 2026 was $2.00. Hence, Elekta AB's PB Ratio of today is 2.62.
The historical rank and industry rank for Elekta AB's PB Ratio or its related term are showing as below:
EKTAF'
s PB Ratio Range Over the Past 10 Years
Min: 1.66 Med: 4.12 Max: 7.11
Current: 2.53
During the past 13 years, Elekta AB's highest PB Ratio was 7.11. The lowest was 1.66. And the median was 4.12.
EKTAF's PB Ratio is ranked worse than 58.32% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs EKTAF: 2.53
During the past 12 months, Elekta AB's average Book Value Per Share Growth Rate was -19.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -10.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -1.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 3.90% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Elekta AB was 27.80% per year. The lowest was -10.00% per year. And the median was 8.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Elekta AB PB Ratio Related Terms
Elekta AB PB Ratio Historical Data
* Premium members only.
The historical data trend for Elekta AB's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Elekta AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elekta AB PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Elekta AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Elekta AB's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Elekta AB (EKTAF) has a PB Ratio of 2.62 as of Jul. 18, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Elekta AB and its competitors. This is 36% below median its historical median of 4.12. Over the past decade, Elekta AB's PB Ratio has ranged from 1.66 to 7.11. According to the industry distribution chart, Elekta AB ranks #459 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 58.3%.
Is Elekta AB's PB Ratio too high?
Elekta AB's current PB Ratio of 2.62 is 36% below median its 10-year median of 4.12. Over the past 10 years, this metric has ranged from a low of 1.66 to a high of 7.11. The Medical Devices & Instruments industry median PB Ratio is 2.05. Elekta AB's value of 2.62 is 27.8% above this industry median. Based on the distribution chart, Elekta AB ranks #459 out of 787 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Elekta AB has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elekta AB's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Elekta AB ranks #459 out of 787 companies for PB Ratio. This places Elekta AB in the lower half of its industry. The industry median PB Ratio is 2.05. Elekta AB's value of 2.62 is 27.8% above this benchmark. Historically, Elekta AB's own PB Ratio has ranged from 1.66 to 7.11 over the past decade. While the company's 10-year median is 4.12 vs. the industry median of 2.05, Elekta AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elekta AB's current PB Ratio of 2.62 is 27.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Elekta AB and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elekta AB's current PB Ratio is 2.62, which is 36% below median its own 10-year median of 4.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elekta AB stock overvalued right now?
Based on GuruFocus' analysis, Elekta AB (EKTAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.70, compared to a current price of $5.25 — trading 21.6% below its estimated fair value. The current PB Ratio is 2.62, which is 36% below median its 10-year median of 4.12 and 27.8% above the Medical Devices & Instruments industry median of 2.05. Elekta AB's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Elekta AB (EKTAF), the current PB Ratio is 2.62 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elekta AB (EKTAF) Overvalued in 2026?
Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued.
The current stock price of $5.25 is trading 21.6% below its estimated GF Value™ of $6.70.
GuruFocus considers Elekta AB to be Modestly Undervalued.
Key valuation signals for EKTAF:
PB Ratio: 2.62 (36% below median its 10-year median of 4.12)
GF Value™: $6.70 vs. price of $5.25 (21.6% below fair value)
Industry Position: 27.8% above the Medical Devices & Instruments median (#459 of 787)
No single metric tells the full story. See the EKTAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
70GF Score
Get the complete analysis for EKTAF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EKTAF has been successfully added to your 
